As of Dec 08
| +0.0052 / +0.65%|
The 5 analysts offering 12-month price forecasts for Synthetic Biologics Inc have a median target of 5.75, with a high estimate of 8.00 and a low estimate of 5.00. The median estimate represents a +609.26% increase from the last price of 0.81.
The current consensus among 5 polled investment analysts is to Buy stock in Synthetic Biologics Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.